A
Arthur M. Feldman
Researcher at Thomas Jefferson University
Publications - 296
Citations - 41891
Arthur M. Feldman is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Heart failure & Tumor necrosis factor alpha. The author has an hindex of 79, co-authored 289 publications receiving 40355 citations. Previous affiliations of Arthur M. Feldman include Johns Hopkins University School of Medicine & Valley Hospital.
Papers
More filters
Journal ArticleDOI
Feasibility of Combined Percutaneous Transluminal Angioplasty and Minimally Invasive Direct Coronary Artery Bypass in Patients With Multivessel Coronary Artery Disease
Howard A. Cohen,Marco A. Zenati,A.J. Conrad Smith,Joon S. Lee,Simon Chough,Zubair Jafar,Peter J. Counihan,Mark Izzo,J.E. Burchenal,Arthur M. Feldman,Bartley P. Griffith +10 more
TL;DR: Preliminary results with ICR are encouraging and suggest that a randomized, prospective clinical trial comparing ICR with standard coronary artery bypass surgery for the revascularization of symptomatic patients with multivessel disease involving the LAD is warranted.
Journal ArticleDOI
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.
Dennis M. McNamara,S. William Tam,Michael L. Sabolinski,Page Tobelmann,Karen Janosko,Lakshmi Venkitachalam,Elizabeth Ofili,Clyde W. Yancy,Arthur M. Feldman,Jalal K. Ghali,Anne L. Taylor,Jay N. Cohn,Manuel Worcel +12 more
TL;DR: In black subjects with heart failure, NOS3 genotype influences blood pressure and left ventricular remodeling and the impact of genetic heterogeneity on treatment with FDC I/H requires further study.
Journal ArticleDOI
Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies
TL;DR: Estrogen use among older women with CHF is associated with decreased overall and cardiac mortality andRegression analysis demonstrated that estrogen use was independently associated with improved survival.
Journal ArticleDOI
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure.
Arthur M. Feldman,Marc A. Silver,Gary S. Francis,Charles W. Abbottsmith,Bruce Fleishman,Ozlem Soran,Paul-Andre de Lame,Thomas Varricchione,Peech Investigators +8 more
TL;DR: In this randomized, single-blinded study, EECP improved exercise tolerance, quality of life, and NYHA functional classification without an accompanying increase in peak VO2.
Journal ArticleDOI
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004
Sana M. Al-Khatib,Gillian D Sanders,Daniel B. Mark,Kerry L. Lee,Gust H. Bardy,J. Thomas Bigger,Alfred E. Buxton,Stuart J. Connolly,Alan H. Kadish,Arthur J. Moss,Arthur M. Feldman,Kenneth A. Ellenbogen,Steven N. Singh,Robert M. Califf +13 more
TL;DR: This document summarizes the evidence reviewed at a 1-day round table to review the impact of ICD therapy in the primary prevention of sudden cardiac death and the effect of CRT in patients with congestive heart failure and the discussions of that evidence.